Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,550 | 1,175 | 98.8% |
| Education | $214.22 | 7 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,511 | 197 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,926 | 108 | $0 (2024) |
| Novo Nordisk Inc | $1,546 | 95 | $0 (2024) |
| Amgen Inc. | $1,066 | 74 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,044 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $876.46 | 60 | $0 (2024) |
| Lilly USA, LLC | $763.52 | 48 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $626.74 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $596.96 | 55 | $0 (2022) |
| Merck Sharp & Dohme LLC | $566.26 | 54 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,498 | 134 | ABBVIE INC. ($338.45) |
| 2023 | $2,026 | 132 | ABBVIE INC. ($506.91) |
| 2022 | $2,485 | 163 | ABBVIE INC. ($549.66) |
| 2021 | $3,024 | 208 | AbbVie Inc. ($593.47) |
| 2020 | $2,413 | 169 | AstraZeneca Pharmaceuticals LP ($391.00) |
| 2019 | $1,813 | 134 | AstraZeneca Pharmaceuticals LP ($288.62) |
| 2018 | $1,868 | 134 | Janssen Pharmaceuticals, Inc ($322.91) |
| 2017 | $1,637 | 108 | Janssen Pharmaceuticals, Inc ($377.91) |
All Payment Transactions
1,182 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Structural Heart | ||||||
| 12/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: PAIN | ||||||
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: PAIN | ||||||
| 12/18/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Oncology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.54 | General |
| Category: Opioid Analgesic | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: Rare Disease | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: PAIN | ||||||
| 10/18/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Oncology | ||||||
| 10/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $47.11 | General |
| Category: Hematology | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 57 | 6,267 | 40,385 | $938,948 | $281,569 |
| 2022 | 58 | 6,864 | 11,914 | $984,067 | $293,392 |
| 2021 | 62 | 6,761 | 31,655 | $1.0M | $309,166 |
| 2020 | 62 | 6,991 | 29,334 | $1.0M | $266,072 |
All Medicare Procedures & Services
239 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 397 | 1,819 | $191,395 | $103,112 | 53.9% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 147 | 297 | $89,100 | $23,471 | 26.3% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 146 | 148 | $44,400 | $16,286 | 36.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 353 | 396 | $37,620 | $11,418 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $18,800 | $11,366 | 60.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 69 | 301 | $25,585 | $11,042 | 43.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 504 | 1,017 | $10,170 | $8,522 | 83.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 437 | 641 | $38,460 | $8,343 | 21.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 471 | 788 | $98,500 | $8,115 | 8.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 79 | 79 | $41,475 | $7,613 | 18.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 340 | 413 | $14,042 | $6,798 | 48.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 330 | 357 | $17,850 | $5,228 | 29.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 437 | 659 | $23,713 | $4,982 | 21.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 82 | 82 | $70,028 | $4,900 | 7.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 317 | 342 | $29,070 | $4,881 | 16.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 144 | 498 | $17,430 | $4,621 | 26.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 85 | 100 | $5,000 | $3,910 | 78.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 86 | 202 | $7,070 | $3,194 | 45.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 205 | 309 | $20,085 | $2,882 | 14.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $3,550 | $2,794 | 78.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $5,200 | $2,207 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 24 | $4,000 | $1,868 | 46.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 132 | 138 | $14,904 | $1,632 | 10.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 83 | 83 | $4,980 | $1,570 | 31.5% |
| 92548 | Test for balance and posture | Office | 2023 | 43 | 43 | $8,600 | $1,471 | 17.1% |
About Dr. John Manchin, DO
Dr. John Manchin, DO is a Rural Health healthcare provider based in Farmington, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134231640.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Manchin, DO has received a total of $17,765 in payments from pharmaceutical and medical device companies, with $2,498 received in 2024. These payments were reported across 1,182 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($17,550).
As a Medicare-enrolled provider, Manchin has provided services to 26,883 Medicare beneficiaries, totaling 113,288 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 239 distinct procedure/service records.
Practice Information
- Specialty Rural Health
- Other Specialties Family Medicine
- Location Farmington, WV
- Active Since 08/31/2006
- Last Updated 06/06/2025
- Taxonomy Code 261QR1300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134231640
Products in Payments
- LINZESS (Drug) $1,040
- FARXIGA (Drug) $838.39
- Ozempic (Drug) $645.24
- UBRELVY (Drug) $633.03
- INVOKANA (Drug) $610.37
- TRADJENTA (Drug) $551.78
- Vascepa (Drug) $514.19
- SYMBICORT (Drug) $463.63
- Rybelsus (Drug) $461.71
- Otezla (Drug) $417.67
- XARELTO (Drug) $414.51
- JANUVIA (Drug) $332.58
- XIFAXAN (Drug) $331.03
- JARDIANCE (Drug) $330.15
- Creon (Drug) $330.10
- ACCRUFER (Drug) $315.55
- TRINTELLIX (Drug) $287.32
- TRELEGY ELLIPTA (Drug) $285.18
- QULIPTA (Drug) $272.55
- Cologuard Collection Kit (Device) $265.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.